{{Rsnum
|rsid=2019960
|Chromosome=8
|position=128180025
|Orientation=plus
|GMAF=0.2433
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 5.3 | 38.1 | 56.6
| HCB | 0.0 | 13.9 | 86.1
| JPT | 1.8 | 24.8 | 73.5
| YRI | 18.4 | 57.1 | 24.5
| ASW | 24.6 | 42.1 | 33.3
| CHB | 0.0 | 13.9 | 86.1
| CHD | 0.0 | 4.6 | 95.4
| GIH | 4.0 | 25.7 | 70.3
| LWK | 20.9 | 49.1 | 30.0
| MEX | 3.4 | 41.4 | 55.2
| MKK | 16.0 | 41.0 | 42.9
| TSI | 3.9 | 23.5 | 72.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=21037568
|Title=A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)
}}

{{PMID Auto GWAS
|PMID=21833088
|Trait=None
|Title=Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
|RiskAllele=G
|Pval=5E-9
|OR=1.1200
|ORtxt=[1.10-1.13]
|OA=1
}}

[[Hodgkin lymphoma]]

{{PMID Auto GWAS
  |PMID=24149102
  |Trait=Hodgkin's lymphoma
  |Title=Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.
  |RiskAllele=G
  |Pval=6E-10
  |OR=1.37
  |ORtxt=[NR]
  }}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}